Cytotoxic lymphocytes in infectious mononucleosis

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Infectious mononucleosis (IM) is a common viral illness.
• Epstein-Barr virus (EBV) is the primary cause of IM.
• EBV is also associated with certain cancers, such as Burkitt's lymphoma.

Purpose of the Study:

• To investigate the presence and persistence of cytotoxic lymphocytes against EBV-infected cells in patients with infectious mononucleosis.
• To determine the correlation between heterophil antibodies, clinical symptoms, and cytotoxic lymphocyte activity in IM patients.
• To assess the impact of immunosuppressive treatment on cytotoxic lymphocyte function.

Main Methods:

• Peripheral blood lymphocytes were isolated from patients diagnosed with IM.
• Lymphocytes were tested for cytotoxic activity against EBV-infected lymphoid cells from a Burkitt's lymphoma patient.
• Heterophil antibody levels and clinical symptoms were monitored.
• The effect of prednisone treatment on lymphocyte cytotoxicity was evaluated.

Main Results:

• Seven IM patients with detectable heterophil antibodies exhibited peripheral blood lymphocytes cytotoxic to EBV-infected lymphoid cells.
• These cytotoxic lymphocytes persisted for up to 45 days in the circulation.
• Patients with a history of IM (1-5 years prior) lacked these specific cytotoxic lymphocytes.
• Individuals with IM symptoms but without heterophil antibodies did not possess cytotoxic lymphocytes.
• Prednisone treatment led to a progressive decrease in cytotoxic ability in one patient.

Conclusions:

• Active infectious mononucleosis is associated with the emergence of circulating lymphocytes capable of targeting EBV-infected cells.
• The presence of these cytotoxic lymphocytes is linked to heterophil antibody status and active infection.
• The cytotoxic response appears transient, diminishing after the acute phase of IM and potentially suppressed by corticosteroid treatment.